Review: taking Warfarin sodium and Vitamin d together


Summary

Drug interactions are reported among people who take Warfarin sodium and Vitamin d together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Vitamin d. It is created by eHealthMe based on reports of 3,224 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 53,624 users)

Vitamin D

Vitamin d has active ingredients of ergocalciferol. It is often used in vitamin supplementation. (latest outcomes from Vitamin d 47,419 users)

On Sep, 20, 2016

3,224 people who take Warfarin Sodium, Vitamin D are studied.


Number of reports submitted per year:

Warfarin sodium and Vitamin d drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 70.0% - (7 of 10 people)
  • 6 - 12 months: 57.0% - (4 of 7 people)
  • 1 - 2 years: 57.0% - (4 of 7 people)
  • 2 - 5 years: 63.0% - (7 of 11 people)
  • 5 - 10 years: 83.0% - (10 of 12 people)
  • 10+ years: 91.0% - (11 of 12 people)
  • not specified: 0.0% - (0 of 0 people)
Vitamin D:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 46.0% - (6 of 13 people)
  • 6 - 12 months: 25.0% - (2 of 8 people)
  • 1 - 2 years: 42.0% - (6 of 14 people)
  • 2 - 5 years: 44.0% - (4 of 9 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 60.0% - (3 of 5 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 71.0% - (25 of 35 people)
  • male: 73.0% - (19 of 26 people)
Vitamin D:
  • female: 46.0% - (13 of 28 people)
  • male: 37.0% - (10 of 27 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 62.0% - (5 of 8 people)
  • 50-59: 66.0% - (12 of 18 people)
  • 60+: 78.0% - (25 of 32 people)
Vitamin D:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 14.0% - (1 of 7 people)
  • 50-59: 60.0% - (9 of 15 people)
  • 60+: 38.0% - (12 of 31 people)

Most common drug interactions over time *:

< 1 month:
  • sepsis
  • subdural haematoma
  • cardiac failure congestive
  • hypertension
  • international normalised ratio increased
  • haemoglobin decreased
  • headache
  • rhabdomyolysis
  • acute myocardial infarction
  • pancytopenia
1 - 6 months:
  • hepatitis acute
  • international normalised ratio increased
  • dizziness
  • headache
  • pneumonia
  • constipation
  • thrombocytopenia
  • anaemia
  • asthenia
  • female genital tract fistula
6 - 12 months:
  • pancytopenia
  • sepsis
  • dizziness
  • electrolyte imbalance
  • stroke
  • anaemia
  • pneumonitis
  • cardiac arrest
  • dyspnoea
  • epistaxis
1 - 2 years:
  • diarrhoea
  • hives
  • hypertension
  • itching
  • muscle oedema
  • rash generalised
  • urticaria
  • gastrointestinal haemorrhage
  • hyperlipidaemia
  • septic shock
2 - 5 years:
  • dizziness
  • muscle twitching
  • short-term memory loss
  • depression
  • cognitive deterioration
  • diarrhoea
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
5 - 10 years:
  • weakness
  • cognitive deterioration
  • depression
  • dizziness
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle twitching
10+ years:
  • hives
  • itching
  • rash generalised
  • urticaria
  • death
  • erectile dysfunction
  • liver function tests nos abnormal
  • anaemia
  • blood pressure systolic inspiratory decreased
  • cardiac failure congestive
not specified:
  • fatigue
  • dyspnoea
  • pain
  • fall
  • diarrhoea
  • nausea
  • dizziness
  • asthenia
  • headache
  • pneumonia

Most common drug interactions by gender *:

female:
  • dyspnoea
  • pain
  • fatigue
  • fall
  • headache
  • diarrhoea
  • nausea
  • dizziness
  • asthenia
  • pain in extremity
male:
  • fatigue
  • dyspnoea
  • fall
  • asthenia
  • dizziness
  • diarrhoea
  • international normalised ratio increased
  • pneumonia
  • pain
  • drug ineffective

Most common drug interactions by age *:

2-9:
  • adrenocortical insufficiency acute
  • international normalised ratio increased
  • anaemia
  • drug administration error
  • dysphonia
  • fall
  • femur fracture
  • headache
  • hip fracture
  • hyponatraemia
10-19:
  • abdominal pain
  • atrial fibrillation
  • bronchitis
  • depression
  • dyspnoea
  • fatigue
  • thrombosis
  • abdominal mass
  • abdominal pain upper
  • actinomycosis
20-29:
  • nausea
  • diarrhoea
  • pain
  • pyrexia
  • vomiting
  • arthralgia
  • fatigue
  • back pain
  • dyspnoea
  • chest pain
30-39:
  • nausea
  • dyspnoea
  • back pain
  • flushing
  • headache
  • pain in extremity
  • vomiting
  • abdominal discomfort
  • chest pain
  • drug ineffective
40-49:
  • headache
  • dyspnoea
  • pain in extremity
  • dizziness
  • cataract
  • pain
  • anxiety
  • dyspepsia
  • nausea
  • asthenia
50-59:
  • dyspnoea
  • pain
  • dizziness
  • fatigue
  • international normalised ratio increased
  • nausea
  • fall
  • anxiety
  • headache
  • diarrhoea
60+:
  • fatigue
  • dyspnoea
  • fall
  • diarrhoea
  • pain
  • asthenia
  • pneumonia
  • atrial fibrillation
  • nausea
  • headache

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Vitamin d?

Can you answer these questions?

More questions for: Warfarin sodium, Vitamin d

You may be interested in these reviews

More reviews for: Warfarin sodium, Vitamin d

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Vitamin d (ergocalciferol) is often used to treat vitamin supplementation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.